HQ5-37121-72387
2 vaccinations
1 coded response
2 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 940 / CA
- Registered
- 2022-10-16
- Relationship
- Child or adolescent in my care
- Guardian
- 67R-24533-11688
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-28
Dose 1 — Moderna
-
2022-07-26
Dose 2 — Moderna
-
2022-10-16
Registered in v-safe
- 2022-10-25
-
2023-01-24
Survey response — 6 months, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-28 | Moderna | No |
| 2 | 2022-07-26 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release